Abstract Purpose of Review Suicide is a major public health concern and a leading cause of
death in the US. Alcohol and opioid use disorders (AUD/OUD) significantly increase risk for …

Addiction to drugs is a chronic, relapsing brain disease that has major medical, social, and
economic complications. It has been established that genetic factors contribute to the …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Music's universality and its ability to deeply affect emotions suggest an evolutionary origin.
Previous investigators have found that naltrexone (NTX), a μ-opioid antagonist, may induce …

Context Sustained-release naltrexone implants may improve outcomes of nonagonist
treatment of opioid addiction. Objective To compare outcomes of naltrexone implants, oral …

Studies conducted in rodents indicate a crucial role of the opioid circuit in mediating
objective hedonic reactions to primary rewards. However, it remains unclear whether opioid …

Extended‐release naltrexone (XR‐NTX; Vivitrol®), developed to address poor adherence in
addictive disorders, is approved for use in alcohol and opioid‐dependence disorders. In …

Introduction: Broadly defined behavioral addiction is a conceptual framework including
behaviors characterized by loss of control and continuation despite significant negative …

Importance Extended-release naltrexone (XR-NTX) is a promising alternative treatment of
opioid addiction but has never been compared with opioid agonist treatment for effects on …

Objective The United States is amidst an opioid epidemic, including synthetic opioids that
may result in rapid death, leaving minimal opportunity for bystander rescue. We pilot tested a …